Stock Events

Stock Events

Achieve Life Sciences 

€2.48
69
+€0.19+8.3% Today

Statistics

Day High
2.29
Day Low
2.29
52W High
4.91
52W Low
1.76
Volume
-
Avg. Volume
-
Mkt Cap
132.02M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7MayExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Next
-0.38
-0.33
-0.29
-0.24
Expected EPS
-0.303333
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-75.56MNet Income

Analyst Ratings

$11.76Average Price Target
The highest estimate is 14.42.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
50%
Hold
50%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SP4P.F. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is involved in developing treatments in various therapeutic areas, including smoking cessation aids which compete with Achieve Life Sciences' cytisinicline product.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline produces Nicorette, a nicotine replacement therapy, directly competing with Achieve's smoking cessation products.
Altria Group
MO
Mkt Cap94.64B
Altria Group, through its investments in nicotine replacement and cessation products, competes in the same market as Achieve Life Sciences.
British American Tobacco
BTI
Mkt Cap111.84B
British American Tobacco, with its investments in smoking cessation tools and nicotine replacement therapies, competes with Achieve Life Sciences.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its subsidiary producing Nicorette, competes in the nicotine replacement therapy market.
Novartis
NVS
Mkt Cap237.61B
Novartis offers smoking cessation products, which places it in direct competition with Achieve Life Sciences.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. competes through its research and development in therapies that could potentially include smoking cessation aids.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie, with its broad interest in healthcare solutions, could potentially compete in the smoking cessation aid market.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap23.49B
Teva Pharmaceutical Industries competes in the generic drug market, including potential production of smoking cessation aids.
22nd Century Group
XXII
Mkt Cap5.71M
22nd Century Group, Inc. specializes in tobacco products with reduced nicotine levels, indirectly competing with smoking cessation aids.

About

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.
Show more...
CEO
Dr. Richard A. B. Stewart
Employees
25
Country
US
ISIN
US0044685008
WKN
000A2QAR3

Listings

XNAS
US
ACHV
F
DE
SP4P.F
BOATS
BOATS
ACHV.BOATS

0 Comments

Share your thoughts

FAQ

What is Achieve Life Sciences stock price today?▼
The current price of SP4P.F is €2.48 EUR — it has increased by +8.3% in the past 24 hours. Watch Achieve Life Sciences stock price performance more closely on the chart.
What is Achieve Life Sciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Achieve Life Sciences stocks are traded under the ticker SP4P.F.
Is Achieve Life Sciences stock price growing?▼
SP4P.F stock has fallen by -0.6% compared to the previous week, the month change is a -37.22% fall, over the last year Achieve Life Sciences has showed a +1.85% increase.
What is Achieve Life Sciences market cap?▼
Today Achieve Life Sciences has the market capitalization of 132.02M
When is the next Achieve Life Sciences earnings date?▼
Achieve Life Sciences is going to release the next earnings report on May 07, 2026.
What were Achieve Life Sciences earnings last quarter?▼
SP4P.F earnings for the last quarter are -0.24 EUR per share, whereas the estimation was -0.21 EUR resulting in a -14.75% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Achieve Life Sciences revenue for the last year?▼
Achieve Life Sciences revenue for the last year amounts to 0 EUR.
What is Achieve Life Sciences net income for the last year?▼
SP4P.F net income for the last year is -75.56M EUR.
How many employees does Achieve Life Sciences have?▼
As of April 01, 2026, the company has 25 employees.
In which sector is Achieve Life Sciences located?▼
Achieve Life Sciences operates in the Health Care sector.
When did Achieve Life Sciences complete a stock split?▼
The last stock split for Achieve Life Sciences was on August 03, 2020 with a ratio of 1:20.
Where is Achieve Life Sciences headquartered?▼
Achieve Life Sciences is headquartered in Bothell, US.